4.4 Article

Dendritic cell immunotherapy for autoimmune diabetes

Journal

IMMUNOLOGIC RESEARCH
Volume 36, Issue 1-3, Pages 167-173

Publisher

HUMANA PRESS INC
DOI: 10.1385/IR:36:1:167

Keywords

dendritic cells; type 1 diabetes; autoimmunity; immunotherapy

Categories

Funding

  1. NCI NIH HHS [P01 CA073743, CA73743] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [P01CA073743] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Dendritic cells (DC) play important roles in the initiation of immune responses and maintenance of self-tolerance. We have been studying the role of DC in the pathogenesis of type I diabetes and exploring the ability of specific DC subsets to prevent diabetes in non-obese diabetic (NOD) mice. DC subsets that prevent diabetes in this model have a mature phenotype and induce the production of regulatory Th2 cells. We review here recent advances in this area and highlight the importance of optimizing culture conditions and purification methods in the isolation of therapeutic DC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available